Biogen's (BIIB) President and CEO, Jim Mullen, to Retire
Tweet Send to a Friend
Biogen Idec (NASDAQ: BIIB) today announced that James Mullen, President and CEO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
